Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2025-12-24 @ 4:46 PM
NCT ID:
NCT00094250
Eligibility Criteria:
Inclusion Criteria:
* Class II and III CHF that has been clinically stable for at least 6 months
* Systolic ejection fraction (LVEF) between 20% and 40%
* Under the care of a cardiologist who is willing to have the patient participate in the study and who will continue to follow the patient medically during his/her participation
* Willing and able to undergo the screening procedures and the 1 month observation period to determine eligibility
* Willing and able to come to the research center three times a week for 4 months to participate in an exercise program consisting of either aerobic exercise only, or aerobic exercise plus resistance training
* Able to speak and read English
* Willing to participate in the study after having the study explained to him/her and has signed an informed consent form
Exclusion Criteria:
* Eligible for a cardiac rehabilitation program under Medicare rules due to a recent acute event
* Any medical condition that would make either exercise unsafe or uncomfortable, such as symptomatic COPD, severe arthritis, severe peripheral vascular disease, unstable heart disease, uncontrolled blood pressure, or neurological conditions
* Other complicating diseases, such as severe anemia or other blood dyscrasia affecting function, chronic renal failure, progressive cancer, or unstable diabetes
* Does not otherwise meet the above inclusion criteria
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Maximum Age:
90 Years
Study:
NCT00094250
Study Brief:
Protocol Section:
NCT00094250